FreeTCCL Archive Vaccine Increases PFS by 4 Months in Phase II Per-Protocol Analysis June 30, 2014Vol.37 No.06
FreeTCCL Archive Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months June 30, 2014Vol.37 No.06
FreeTCCL Archive Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III June 30, 2014Vol.37 No.06
FreeTCCL Archive Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy June 30, 2014Vol.37 No.06
FreeTCCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 30, 2014Vol.37 No.06
FreeTCCL Archive Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib June 30, 2014Vol.37 No.06
FreeTCCL Archive Anti-Nausea Drug Successful in Phase III Trial in Highly Emetogenic Chemotherapy May 29, 2014Vol.37 No.05
